期刊文献+

伏立康唑联用糖皮质激素致谵妄1例 被引量:6

Voriconazole Combined Glucocorticoid Induced Delirium:Case Report
下载PDF
导出
摘要 1例83岁男性患者,因干咳6月、呼吸困难4天入院。入院时病情危重,诊断为重症肺炎,不排除放射性肺炎,Ⅰ型呼吸衰竭。联用注射用甲泼尼龙琥珀酸钠和抗真菌药伏立康唑期间,患者出现躁动明显、幻听幻视等谵妄症状。临床药师通过参与患者的药物治疗,探讨合并用药致谵妄的可能机制,为药学监护提出建议。 An 83-year-old male patient was admitted to our emergency department because of dry cough for 6 months and dyspnea for 4 days. He was in a critical condition with diagnoses of severe pneumonia, radioactive pneumonia not excluded, and type I respiratory failure. There appears some neuropsychiatric changes in the patient such as restless, auditory, visual hallucination, and other symptoms of delirium when used prednisolone sodium succinate in combination with Voriconazole, an antifungal drugs. Through the participation in patient's medication therapy and literature review, the author discussed the possible mechanisms of drug combination which cause delirium to offer advice for pharmaceutical care.
出处 《药品评价》 CAS 2015年第10期41-44,共4页 Drug Evaluation
关键词 伏立康唑 糖皮质激素 谵妄 Voriconazole Corticosteroid Delirium
  • 相关文献

参考文献19

  • 1官东秀,冯祚臻,俸小平,谭跃.伏立康唑药物不良反应文献分析[J].齐鲁药事,2009,28(8):507-508. 被引量:51
  • 2MorandiA,JacksonJC,ElyEW.Deliriumintheintensivecareunit [J] .Int RevPsychiatry,2009,21 ( 1 ):43-58.
  • 3American Psychiatric Association. Diagnostic and statistical manual of mental disorders [M].4th ed.Washington: American Psychiatric Associatiort,2000:135-147.
  • 4Kavanagh BP, Gottfried SB,et al. Incidence risk factors and consequences of ICU delirium [J].Intensive CareMed,2007, 33(1): 66-73.
  • 5朱萍,蒋正立.伏立康唑的不良反应综述[J].中国药业,2011,20(23):95-96. 被引量:21
  • 6Pascual A, Calandra T, Bolay S, et al. Voriconazoletherapeutic drug monitoring in patients with invasive mycoses improves efficacyand safety outcomes[J]. Clin Infect Dis, 2008,46(2):201-211.
  • 7Boyd AE, Modi S, Howard S J, et al. Adverse reactionsto voriconazole[J]. Clin Infect Dis,2004,39(8): 1241-1244.
  • 8戴志初,蔡绍曦,赵海金,康静,刘来昱.伏立康唑致精神障碍的临床特征和危险因素分析[J].浙江临床医学,2012,14(4):393-396. 被引量:23
  • 9Jeu L, Piacenti F J, Lyakhovetskiy AG, et al. Voriconazole[J]. ClinTher, 2003,25(5):1321-1281.
  • 10付丽芳,赖善城.药物引起神经精神症状不良反应文献统计分析[J].西藏医药,2011,32(4):52-53. 被引量:1

二级参考文献88

共引文献112

同被引文献65

  • 1李敏,周丽娟,张华,郭志强,秦福丽,高延秋.CYP2C19基因多态性对侵袭性真菌感染患者伏立康唑用药的指导意义探讨[J].中国医院药学杂志,2020,40(2):156-160. 被引量:9
  • 2仓怀芹,初向华,董加花,梁瑜,张晓宇.环孢素联合伏立康唑致儿童高血压及神经系统毒性1例[J].药物流行病学杂志,2020,29(3):212-214. 被引量:1
  • 3沈银忠.伏立康唑的临床合理应用[J].世界临床药物,2009,30(12):715-720. 被引量:16
  • 4王欣然,丹金秀,韩斌茹,杨玉萍.老年人术后谵妄的原因分析[J].中华护理杂志,1996,31(8):446-447. 被引量:31
  • 5Hicheri Y1,Cook G,Cordonnier C.Antifungal prophylaxis in haematology patients:the role of voriconazo[J].Clin Microbiol Infect,2012,18(2):1-15.
  • 6Jeu L,Piacenti F J,Lyakhovetskiy A G,et al.Voriconazole[J].Clin Therapeut,2003,25(5):1321-1381.
  • 7Pascual Al,Calandra T,Bolay S,et al.Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes[J].Clin Infect Dis,2008,46(2):201-211.
  • 8Andres P,Chantal C,Thierry B,et al.Challenging Recommended Oral and Intravenous Voriconazole Doses for Improved Efficacyand Safety:Population Pharmacokinetics-Based Analysis in Adult Patients with Invasive Fungal Infections[J].Clin Infect Dis,2012,55(3):381-390.
  • 9Boyd A E,Modi S,Howard S J,et al.Adverse react ions to voriconazole[J].Clin Infect Dis,2004,39(8):1241-1244.
  • 10Park W Bl,Kim N H,Kim K H,et al.The effect of therapeutic drug monitoring on safety and efficacy of voriconazole in invasive fungal infections:a randomized controlled trial[J].Clin Infect Dis,2012,55(8):1080-1087.

引证文献6

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部